eHealth solutions for diabetes - revenue in European countries 2016

The graph presents a forecast of European countries ranked by eHealth diabetes market revenue in 2016. According to the estimates, eHealth revenue of the diabetes segment will be highest in Germany, with a market value of 30.9 million U.S. dollars. An overview of all Digital Markets can be found here.
Statista’s Digital Market Outlook offers forecasts, detailed market insights and essential performance indicators of the most significant areas in the “Digital Economy”, including various digital goods and services. Alongside revenue forecasts for 50 countries worldwide, Statista offers additional insights into consumer trends and demographic structure of digital consumer markets.

Revenue of eHealth solutions for diabetes in selected European countries in 2016 (in million U.S. dollars)

Characteristic	Revenue in million U.S. dollars
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

February 2016

More information

Region

Europe

Survey time period

2016*

Supplementary notes

* Estimate.

The Diabetes segment includes the user and revenue development for three eHealth product categories for people with diabetes: (1) connected medical devices designed for diabetes patients to use at home (Smart Devices), (2) digital diabetes applications for smartphone and/or tablets (Apps) and (3) telemedical services for diabetes patients (Telemedical Services). Hardware and software solutions for healthcare professionals, e.g. medical equipment for hospitals and doctors’ surgeries are not included.

The Smart Devices segment covers medical diabetes devices (hardware) which are equipped with dedicated interfaces or SIM cards that serve to transmit measurement data across a wireless connection (e.g. via mobile networks, WiFi, bluetooth, M2M technologies, NFC, BLE). For example, connected glucose meters, systems for continuous glucose monitoring (CGMs) or connected insulin injection devices (e.g. Telcare, Freestyle Libre from Abbott or the MiniMed Veo Insulin Pump from Medtronic). The measurement data can be sent to a smartphone and be synchronized with an app or, when there is an increased need for monitoring, the data can also be sent to a telemedical service center. Depending on the measuring system, additional hardware revenues can fall under this market segment if additional reading or transmitting devices are implemented.
Further information on methodology can be found here.

Citation formats